How does high hsCRP relate to heart disease risk?

High-sensitivity C-reactive protein (hsCRP) is a key marker of inflammation that strongly predicts heart disease risk, with levels above 3 mg/L indicating high cardiovascular risk. Regular testing combined with lifestyle changes can help reduce both hsCRP levels and heart disease risk.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding hsCRP and Its Role in Heart Health

High-sensitivity C-reactive protein (hsCRP) is a protein produced by your liver in response to inflammation throughout your body. While standard CRP tests detect high levels of inflammation from acute conditions like infections or injuries, the high-sensitivity version can detect much lower levels of chronic, low-grade inflammation that often flies under the radar but significantly impacts your cardiovascular health.

This subtle inflammation plays a crucial role in the development of atherosclerosis, the buildup of plaque in your arteries that leads to heart disease. When inflammation persists in your blood vessels, it damages the arterial walls, making them more susceptible to plaque formation. Over time, this process narrows your arteries and increases your risk of heart attacks, strokes, and other cardiovascular events.

Research has consistently shown that hsCRP is an independent predictor of cardiovascular disease, meaning it provides valuable risk information beyond traditional factors like cholesterol levels and blood pressure. In fact, studies indicate that people with high hsCRP levels have up to twice the risk of heart disease compared to those with low levels, even when other risk factors are normal. Understanding your hsCRP levels through regular testing gives you a powerful tool for assessing and managing your heart disease risk.

What Do Different hsCRP Levels Mean?

Understanding your hsCRP test results is essential for evaluating your cardiovascular risk. The American Heart Association and Centers for Disease Control and Prevention have established clear guidelines for interpreting hsCRP levels in the context of heart disease risk assessment.

Low risk (less than 1.0 mg/L) indicates minimal inflammation and the lowest cardiovascular risk. This is the optimal range to maintain for heart health. Average risk (1.0 to 3.0 mg/L) suggests moderate inflammation that warrants attention through lifestyle modifications. High risk (above 3.0 mg/L) indicates significant inflammation and substantially elevated cardiovascular risk, requiring immediate action and possibly medical intervention.

It's important to note that very high levels (above 10 mg/L) typically indicate acute inflammation from infection, injury, or other conditions rather than the chronic inflammation associated with heart disease. In such cases, the test should be repeated once the acute condition resolves to get an accurate cardiovascular risk assessment.

Factors That Can Temporarily Elevate hsCRP

Several factors can cause temporary spikes in hsCRP that don't necessarily reflect your cardiovascular risk. Recent infections, injuries, or surgeries can dramatically increase levels. Pregnancy, especially in the third trimester, naturally elevates hsCRP. Certain medications, including hormone replacement therapy and some birth control pills, can also affect readings. For the most accurate assessment, it's best to test when you're feeling well and haven't had recent illnesses or injuries.

The Connection Between hsCRP and Cardiovascular Disease

The relationship between elevated hsCRP and heart disease involves multiple interconnected mechanisms. Chronic inflammation damages the endothelium, the inner lining of blood vessels, making it easier for cholesterol to penetrate and accumulate. This process initiates the formation of atherosclerotic plaques, which narrow arteries and restrict blood flow.

More concerning is inflammation's role in plaque instability. High levels of inflammation can cause existing plaques to rupture, triggering blood clots that can completely block arteries and cause heart attacks or strokes. This explains why some people with relatively modest cholesterol levels still experience cardiovascular events - the inflammatory component was the missing piece of their risk profile.

Research from the JUPITER trial demonstrated that people with normal LDL cholesterol but elevated hsCRP benefited significantly from statin therapy, reducing their risk of heart attacks, strokes, and cardiovascular death by nearly 50%. This groundbreaking study highlighted that addressing inflammation is just as important as managing cholesterol for comprehensive cardiovascular protection.

hsCRP and Other Cardiovascular Risk Factors

hsCRP doesn't work in isolation but interacts with other cardiovascular risk factors to compound your overall risk. People with both high hsCRP and high LDL cholesterol face particularly elevated risk, as inflammation accelerates the process by which cholesterol damages arteries. Similarly, the combination of high hsCRP and hypertension creates a dangerous synergy, with inflammation making blood vessels less flexible and more prone to damage from elevated pressure.

Common Causes of Elevated hsCRP

Understanding what drives chronic inflammation helps you address the root causes of elevated hsCRP. Poor dietary choices, particularly diets high in processed foods, refined sugars, and unhealthy fats, are major contributors. These foods trigger inflammatory responses and promote the production of inflammatory compounds throughout your body.

Excess body weight, especially abdominal obesity, is another significant factor. Fat tissue, particularly visceral fat around your organs, actively produces inflammatory substances including CRP. This creates a vicious cycle where inflammation promotes further weight gain and metabolic dysfunction.

  • Chronic stress and poor sleep quality, which elevate cortisol and disrupt immune function
  • Sedentary lifestyle, as regular physical activity has powerful anti-inflammatory effects
  • Smoking and excessive alcohol consumption, both direct triggers of systemic inflammation
  • Underlying conditions like diabetes, metabolic syndrome, and autoimmune disorders
  • Chronic infections, including gum disease and certain viral infections
  • Environmental toxins and air pollution exposure

The Role of Genetics

While lifestyle factors play the dominant role, genetics also influence your baseline hsCRP levels. Some people naturally produce more CRP in response to inflammatory triggers. However, having a genetic predisposition doesn't mean elevated levels are inevitable. Lifestyle modifications can often overcome genetic tendencies, making it crucial to focus on what you can control rather than genetic factors you cannot change.

Strategies to Lower hsCRP and Reduce Heart Disease Risk

The good news is that hsCRP levels respond remarkably well to lifestyle interventions. Unlike some cardiovascular risk factors that require medication, many people can significantly reduce their hsCRP through targeted lifestyle changes alone.

Dietary Approaches

Adopting an anti-inflammatory diet is one of the most powerful ways to lower hsCRP. The Mediterranean diet, rich in fruits, vegetables, whole grains, fish, and olive oil, has been shown to reduce hsCRP levels by up to 20% in just a few months. Key dietary strategies include:

  • Increasing omega-3 fatty acids from fish, walnuts, and flaxseeds
  • Loading up on colorful fruits and vegetables high in antioxidants
  • Choosing whole grains over refined carbohydrates
  • Limiting red meat and processed meats
  • Reducing sugar and high-fructose corn syrup intake
  • Including anti-inflammatory spices like turmeric and ginger

Exercise and Physical Activity

Regular physical activity is a potent anti-inflammatory intervention. Both aerobic exercise and strength training reduce hsCRP levels, with studies showing reductions of 20-40% in people who exercise regularly. Aim for at least 150 minutes of moderate-intensity exercise weekly, combining cardiovascular activities with resistance training for optimal benefits.

Weight Management and Other Lifestyle Factors

Even modest weight loss can significantly impact hsCRP levels. Studies show that losing just 5-10% of body weight can reduce hsCRP by 25-50%. Additionally, managing stress through meditation, yoga, or other relaxation techniques helps lower inflammatory markers. Prioritizing sleep quality and aiming for 7-9 hours nightly also supports healthy hsCRP levels.

When to Consider Medical Intervention

While lifestyle modifications form the foundation of hsCRP management, some situations warrant medical intervention. If your hsCRP remains elevated despite consistent lifestyle changes, or if you have multiple cardiovascular risk factors, medication may be appropriate.

Statins, primarily prescribed for cholesterol management, also have powerful anti-inflammatory effects and can reduce hsCRP by 15-40%. For people with persistently high hsCRP and other risk factors, the cardiovascular benefits often outweigh potential side effects. Other medications that may help include aspirin for selected high-risk individuals and certain diabetes medications that have anti-inflammatory properties.

The decision to use medication should be made in consultation with your healthcare provider, considering your overall cardiovascular risk profile, not just hsCRP levels alone. Regular monitoring helps track your response to interventions and adjust your treatment plan as needed.

The Importance of Regular Monitoring

Since hsCRP levels can fluctuate based on various factors, single measurements may not tell the complete story. Regular monitoring provides a more accurate picture of your inflammatory status and cardiovascular risk over time. Most experts recommend testing hsCRP along with other cardiovascular markers at least annually, or more frequently if you're actively working to reduce elevated levels.

Tracking hsCRP alongside other biomarkers like cholesterol panels, blood pressure, and metabolic markers gives you and your healthcare provider comprehensive insights into your cardiovascular health. This integrated approach enables more personalized and effective prevention strategies. Regular testing also helps you see the impact of your lifestyle changes, providing motivation to maintain healthy habits.

Taking Action for Heart Health

Understanding the connection between hsCRP and heart disease risk empowers you to take proactive steps for cardiovascular health. While elevated hsCRP indicates increased risk, it also represents an opportunity for intervention. Unlike some risk factors, inflammation responds remarkably well to lifestyle modifications, giving you significant control over this aspect of your heart health.

Start by getting your hsCRP levels tested to establish your baseline. If elevated, implement the dietary and lifestyle strategies discussed, focusing on sustainable changes you can maintain long-term. Work with your healthcare provider to develop a comprehensive cardiovascular risk reduction plan that addresses all your risk factors, not just inflammation.

Remember that reducing hsCRP and cardiovascular risk is a journey, not a destination. Consistent healthy choices compound over time, leading to significant improvements in your inflammatory markers and overall heart health. By taking action today, you're investing in a healthier, more vibrant future with reduced risk of heart disease and its complications.

References

  1. Ridker, P. M., Danielson, E., Fonseca, F. A., et al. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine, 359(21), 2195-2207.[Link][PubMed][DOI]
  2. Emerging Risk Factors Collaboration. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet, 375(9709), 132-140.[PubMed][DOI]
  3. Pearson, T. A., Mensah, G. A., Alexander, R. W., et al. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107(3), 499-511.[Link][PubMed]
  4. Kasapis, C., & Thompson, P. D. (2005). The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. Journal of the American College of Cardiology, 45(10), 1563-1569.[PubMed][DOI]
  5. Esposito, K., Marfella, R., Ciotola, M., et al. (2004). Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA, 292(12), 1440-1446.[PubMed][DOI]
  6. Selvin, E., Paynter, N. P., & Erlinger, T. P. (2007). The effect of weight loss on C-reactive protein: a systematic review. Archives of Internal Medicine, 167(1), 31-39.[PubMed][DOI]

Frequently Asked Questions

How can I test my hsCRP at home?

You can test your hsCRP at home with SiPhox Health's Heart & Metabolic Program or Core Health Program. Both CLIA-certified programs include hsCRP testing along with other essential cardiovascular markers, providing lab-quality results from the comfort of your home.

What is the optimal hsCRP level for heart health?

The optimal hsCRP level for cardiovascular health is less than 1.0 mg/L, which indicates low risk. Levels between 1.0-3.0 mg/L suggest average risk, while levels above 3.0 mg/L indicate high risk for heart disease. However, very high levels above 10 mg/L usually indicate acute inflammation from infection or injury rather than cardiovascular risk.

How quickly can I lower my hsCRP levels?

With consistent lifestyle changes, many people see significant reductions in hsCRP within 4-8 weeks. Dietary improvements and regular exercise can lower levels by 20-40%, while weight loss of 5-10% can reduce hsCRP by 25-50%. However, individual responses vary, and maintaining these changes long-term is crucial for sustained benefits.

Should I take statins if my hsCRP is high but my cholesterol is normal?

This decision requires consultation with your healthcare provider. The JUPITER trial showed that people with normal LDL cholesterol but elevated hsCRP benefited from statin therapy, reducing cardiovascular events by nearly 50%. Your doctor will consider your overall risk profile, including family history, blood pressure, and other factors, not just hsCRP alone.

Can stress really affect my hsCRP levels?

Yes, chronic stress significantly impacts hsCRP levels through multiple mechanisms. Stress hormones like cortisol promote inflammation, while stress often leads to poor sleep, unhealthy eating, and reduced physical activity - all factors that raise hsCRP. Managing stress through meditation, exercise, or counseling can help lower inflammatory markers.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details